Allied Health: The Coronavirus Surge Won't Last

Summary

  • AHPI, a respiratory products manufacturer, has seen its stock price skyrocket recently on coronavirus fears.
  • The stock’s price tends to rise noticeably during viral outbreaks and other health scares, but the company’s underlying financial viability remains questionable.
  • AHPI is spiking again during this coronavirus outbreak, but it likely won’t result in any significant long-term growth.
  • Looking for a helping hand in the market? Members of The Lead-Lag Report get exclusive ideas and guidance to navigate any climate. Get started today »

When my book 'Rich Dad's Prophecy' was released in 2002, most financial newspapers and magazines trashed it because I discussed a looming stock market crash. -- Robert Kiyosaki

Recently, the stock price of Allied Healthcare Products (AHPI) jumped more than 500% over the course of two days in late February, pushing it to new multi-year highs. The catalyst, of course, was the coronavirus outbreak, which has been spreading rapidly across the United States and Europe and has resulted in a surging demand for medical supplies and other healthcare equipment.

AHPI, which specializes in the production of home respiratory care products, oxygen cylinders and emergency medical products, has drawn the attention of investors looking for exposure to companies and industries which figure to benefit from the virus’ spread. The healthcare sector has been one of the market’s best performers over the past month with the medical devices group enjoying particular success. The near-term catalyst has been the development and mass production of a reliable coronavirus test kit, something that, thus far, has proven elusive. Recently, Co-Diagnostics (CODX) has made available its COVID-19 testing kits, boosting the value of other coronavirus names, including AHPI, in the process.

From a fundamental standpoint, however, AHPI could be a trap. This was a stock in the $1-2 range as recently as January and the coronavirus boost could ultimately be little more than a short-term boost for the company.

Investors have certainly been positioning themselves for a move back to the downside as evidenced by the recent short interest chart.

It’s natural that the short interest in any stock, which has risen from $1 to as high as $45 in just a few trading sessions, would increase and could indicate that the recent mania surrounding AHPI has begun to subside. Since the initial spike, AHPI has indeed pulled back to the $15 area, but


Risk-off warnings were given January 27.

Sometimes, you might not realize your biggest portfolio risks until it’s too late.

That’s why it’s important to pay attention to the right market data, analysis, and insights on a daily basis. Being a passive investor puts you at unnecessary risk. When you stay informed on key signals and indicators, you'll take control of your financial future.

My award-winning market research gives you everything you need to know each day, so you can be ready to act when it matters most.

Click here to gain access and try the Lead-Lag Report FREE for 14 days.

This article was written by

30.6K Followers
Michael A. Gayed is portfolio manager, and author of five award-winning research papers on market anomalies and investing. He has a BS with a double major in Finance & Management from NYU Stern School of Business, and is a CFA Charterholder. Michael runs the investing group The Lead-Lag Report, focused on helping investors outperform in all market conditions. It offers a tactical, data-driven approach to investing, to achieve long-term success even in the face of uncertainty. With increasing market volatility, it's essential to understand risk-on/risk-off signals, seize high-yield opportunities, and leverage award-winning research to maximize returns. Learn More.

Analyst’s Disclosure:I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

This writing is for informational purposes only and Lead-Lag Publishing, LLC undertakes no obligation to update this article even if the opinions expressed change. It does not constitute an offer to sell, a solicitation to buy, or a recommendation regarding any securities transaction. It also does not offer to provide advisory or other services in any jurisdiction. The information contained in this writing should not be construed as financial or investment advice on any subject matter. Lead-Lag Publishing, LLC expressly disclaims all liability in respect to actions taken based on any or all of the information on this writing.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About AHPIQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on AHPIQ

Related Stocks

SymbolLast Price% Chg
AHPIQ
--